Cite
HARVARD Citation
van Velzen, A. et al. (2019). Pharmacokinetics and safety of tobramycin nebulization with the I‐neb and PARI‐LC Plus in children with cystic fibrosis: A randomized, crossover study. British journal of clinical pharmacology. 85 (9), pp. 1984-1993. [Online].